Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Ibuprofen prices in Germany, the highest-cost reporting region, rose 5.9% in H1 2026, recovering from USD 18.8/KG in Q1 to USD 19.9/KG by Q2 as Middle East isobutylbenzene supply disruptions and recovering over-the-counter pain relief and fever management demand reversed the brief Q1 feedstock cost softening. Globally, the average rose from USD 13.06/KG in Q1 to USD 13.84/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 14.00-15.40/KG is expected, with continued firming on petrochemical feedstock tightness and growing OTC analgesic and anti-inflammatory sector demand.
Ibuprofen is a non-steroidal anti-inflammatory drug produced predominantly through the Hoechst synthesis route from isobutylbenzene via friedel-crafts acylation followed by Davy reagent hydrogenation and carbonylation, or through the Boot process involving multiple chemical steps. The majority of global ibuprofen API production is concentrated in China and India, using isobutylbenzene derived from petrochemical benzene alkylation as the primary feedstock. The largest pull comes from over-the-counter analgesic and antipyretic formulations for the self-treatment of mild to moderate pain, headache, dental pain, dysmenorrhoea, and fever across regulated and emerging pharmaceutical markets. Additional demand comes from prescription-grade anti-inflammatory formulations for arthritis and musculoskeletal conditions, combination products pairing ibuprofen with decongestants or antihistamines for cold and influenza symptom relief, veterinary pain management formulations for companion animals, and nutraceutical and cosmetic topical formulations. Isobutylbenzene and benzene feedstock costs, OTC analgesic sector demand, seasonal respiratory illness cycles, and regional API production capacity all feed into the price.
The balance of supply and demand for ibuprofen through H2 2026 leans cautiously firm. Isobutylbenzene and benzene feedstock costs firmed from Middle East petrochemical supply disruptions. OTC analgesic and anti-inflammatory demand is growing with expanding self-care pharmaceutical markets and aging population-driven musculoskeletal condition prevalence.
The main upside risk is a sustained isobutylbenzene feedstock cost increase alongside an early and severe cold and influenza season driving OTC analgesic procurement. The main downside risk is continued Chinese ibuprofen API surplus production and competitive export pricing that limits the global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 14.00 - 15.40 | Feedstock firming and OTC demand support tone |
| United States | 14.90 - 16.30 | Steady OTC analgesic and prescription demand holds firm |
| China | 9.40 - 10.80 | Large API capacity keeps it the most affordable |
| Germany | 19.80 - 21.20 | High feedstock and energy costs keep it the most expensive |
| India | 13.40 - 14.80 | Growing OTC and pharma demand holds a firm middle |
US ibuprofen prices averaged USD 16.4/KG in Q2 2026, up 5.8% from USD 15.5/KG in Q1 2026. Firmer isobutylbenzene feedstock costs from Middle East petrochemical supply disruptions elevated production economics. OTC analgesic and prescription anti-inflammatory formulation procurement maintained consistent buying through the quarter.
Why did the price of Ibuprofen change in Q2 2026 in the United States?
Firmer isobutylbenzene and benzene feedstock costs raised the API synthesis production cost floor. OTC analgesic tablet and capsule and anti-inflammatory prescription formulation procurement lifted buying from API suppliers. Combination cold and influenza symptom relief product demand provided additional consistent buying support.
Chinese ibuprofen prices averaged USD 9.9/KG in Q2 2026, up 5.3% from USD 9.4/KG in Q1 2026, the lowest among the tracked markets. Spring pharmaceutical export and OTC formulation procurement lifted buying. Firmer domestic isobutylbenzene costs raised the production floor despite large domestic API capacity.
Why did the price of Ibuprofen change in Q2 2026 in China?
Spring OTC analgesic export and domestic formulation procurement lifted buying from domestic API producers. Firmer domestic isobutylbenzene feedstock costs raised the API synthesis production cost floor. Large domestic ibuprofen API capacity kept China the most affordable source.
German ibuprofen prices averaged USD 19.9/KG in Q2 2026, up 5.9% from USD 18.8/KG in Q1 2026, the highest among the tracked markets. Higher isobutylbenzene and energy costs elevated European API production economics. Recovering OTC analgesic, prescription anti-inflammatory, and combination product demand maintained consistent buying.
Why did the price of Ibuprofen change in Q2 2026 in Germany?
Higher isobutylbenzene feedstock and energy costs elevated European API production economics. Middle East petrochemical supply disruptions added import cost premiums. Recovering OTC analgesic, prescription musculoskeletal, and combination cold product demand maintained consistent procurement.
Indian ibuprofen prices averaged USD 14.9/KG in Q2 2026, up 5.7% from USD 14.1/KG in Q1 2026. Growing OTC pain relief and prescription formulation demand supported buying. Firmer import-linked isobutylbenzene costs raised the production floor through the quarter.
Why did the price of Ibuprofen change in Q2 2026 in India?
Growing OTC analgesic and prescription anti-inflammatory formulation demand lifted procurement from domestic API producers. Firmer import-linked isobutylbenzene feedstock costs raised the production floor. Middle East freight premiums elevated the landed cost of imported API and feedstock.
US ibuprofen prices averaged USD 15.5/KG in Q1 2026, declining from Q4 2025. Post-cold season procurement moderation and softer isobutylbenzene costs reduced the production cost floor near USD 15.5/KG.
Why did the price of Ibuprofen change in Q1 2026 in the United States?
Post-cold and influenza season OTC procurement moderation reduced buying urgency. Softer isobutylbenzene feedstock costs eased the production cost floor. The market eased to USD 15.5/KG before the Q2 2026 spring and Middle East disruption-driven recovery.
Chinese prices averaged USD 9.4/KG in Q1 2026, declining from Q4 2025. Soft isobutylbenzene costs and post-Lunar New Year procurement moderation held the market near USD 9.4/KG.
Why did the price of Ibuprofen change in Q1 2026 in China?
Soft isobutylbenzene feedstock costs eased the production floor. Post-Lunar New Year OTC and pharmaceutical export procurement moderation reduced buying urgency. Large domestic capacity maintained adequate supply near USD 9.4/KG.
German prices averaged USD 18.8/KG in Q1 2026, declining from Q4 2025. Softer isobutylbenzene and energy costs and reduced OTC seasonal procurement eased the market near USD 18.8/KG.
Why did the price of Ibuprofen change in Q1 2026 in Germany?
Softer isobutylbenzene feedstock and energy costs reduced the European production cost floor. Post-cold season OTC procurement moderation reduced buying urgency. The market eased to USD 18.8/KG before the Q2 feedstock-driven recovery.
Indian prices averaged USD 14.1/KG in Q1 2026, declining on the quarter. Softer import-linked feedstock costs and post-seasonal moderation held the market near USD 14.1/KG.
Why did the price of Ibuprofen change in Q1 2026 in India?
Softer import-linked isobutylbenzene feedstock costs eased the production floor. Seasonal OTC procurement moderation reduced urgency. The market eased near USD 14.1/KG before the Q2 Middle East disruption-driven recovery.
Global ibuprofen prices rose through Q3 and Q4 2025 on the OTC cold and influenza season, dipped in Q1 2026 on feedstock cost softness, then surged in Q2 2026 on Middle East supply disruptions. The average rose from USD 12.80/KG in Q2 2025 to USD 13.06/KG in Q3 and USD 13.32/KG in Q4, eased to USD 13.06/KG in Q1 2026, then surged to USD 13.84/KG in Q2 2026, a net gain of about 8.1% over the window. Isobutylbenzene feedstock cycles and OTC analgesic sector demand drove the pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 13.84 | +6.0% | ↑ Rising |
| Q1 2026 | 13.06 | -2.0% | ↓ Falling |
| Q4 2025 | 13.32 | +2.0% | ↑ Rising |
| Q3 2025 | 13.06 | +2.0% | ↑ Rising |
| Q2 2025 | 12.80 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Ibuprofen prices firmed through H2 2025 on the OTC cold and influenza season demand. The global average opened at USD 12.68/KG in Q1 2025 and closed near USD 13.32/KG in Q4, a full-year gain of about 5.1%. Consistent OTC analgesic and anti-inflammatory demand and firming isobutylbenzene costs supported the H2 uptick.
US prices firmed from about USD 15.2/KG in Q1 2025 to USD 15.8/KG by Q4, a gain of 3.9%. Consistent OTC analgesic and prescription anti-inflammatory demand and firming feedstock costs maintained the upward trend.
Chinese prices fell from roughly USD 9.8/KG in Q1 2025 to USD 9.6/KG by Q4, a decline of 2.0%. Large domestic ibuprofen API capacity and competitive export pricing maintained the lowest price level throughout.
German prices firmed from about USD 18.5/KG in Q1 2025 to USD 19.2/KG by Q4, a gain of 3.8%. Consistent OTC analgesic, prescription, and combination product demand and firm feedstock and energy costs supported the market throughout the year.
Indian prices firmed from roughly USD 13.8/KG in Q1 2025 to USD 14.4/KG by Q4, a gain of 4.3%, the strongest in the dataset. Growing OTC pain relief and pharmaceutical formulation demand drove the consistent firming.
Expert Market Research: Your Source for Real-Time Ibuprofen Price Intelligence
Expert Market Research tracks ibuprofen prices continuously across every major producing and consuming region. The team traces causation through isobutylbenzene and benzene feedstock economics, OTC analgesic and anti-inflammatory sector demand cycles, and regional API production capacity. Contact Expert Market Research today for ibuprofen pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Over-the-counter analgesic and antipyretic formulations for self-treatment of pain, headache, dental pain, dysmenorrhoea, and fever take the largest share. Prescription anti-inflammatory for arthritis and musculoskeletal conditions, combination cold and influenza relief products, veterinary pain management, and topical anti-inflammatory formulations also consume significant volumes globally.
The Q2 2026 average was USD 16.4/KG in the United States, USD 9.9/KG in China, USD 19.9/KG in Germany, and USD 14.9/KG in India. Germany remains the highest-priced market.
The global average rose from USD 13.06/KG in Q1 to about USD 13.84/KG in Q2, a gain of around 6.0%. Middle East feedstock disruptions and recovering OTC analgesic demand drove the H1 2026 rebound from the Q1 feedstock cost softening.
Softer isobutylbenzene feedstock costs from moderating crude oil benchmarks reduced the production cost floor. Post-cold and influenza season OTC procurement moderation reduced buying urgency before the Q2 Middle East-driven recovery.
The global average is expected in the USD 14.00 to 15.40/KG range for H2 2026, with continued firming as isobutylbenzene feedstock costs stay elevated and OTC and prescription anti-inflammatory demand grows.
Germany sits highest on feedstock and energy costs, the United States and India hold a firm middle on OTC and prescription demand, and China prices lowest on large domestic API production.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to isobutylbenzene and benzene feedstock costs, OTC cold and influenza season demand cycles, and prescription anti-inflammatory market trends. Middle East petrochemical supply events and seasonal illness prevalence are key signals.
Asia Pacific leads with China holding the largest ibuprofen API synthesis capacity, followed by India and Europe. Any isobutylbenzene or benzene cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time OTC and prescription formulation contracts around seasonal demand cycles, build cover when isobutylbenzene signals tightening, and monitor crude oil and benzene cost trends as primary upstream feedstock signals.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.